RT Journal Article
SR Electronic
T1 <em>In situ</em> transcriptional profile of a germinal center plasmablastic burst hints at <em>MYD88/CD79B</em> mutants-enriched Diffuse Large B-cell Lymphomas
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.28.21261117
DO 10.1101/2021.07.28.21261117
A1 L’Imperio, Vincenzo
A1 Morello, Gaia
A1 Vegliante, Maria Carmela
A1 Cancila, Valeria
A1 Bertolazzi, Giorgio
A1 Mazzara, Saveria
A1 Belmonte, Beatrice
A1 Balzarini, Piera
A1 Corral, Lilia
A1 Napoli, Arianna Di
A1 Facchetti, Fabio
A1 Pagni, Fabio
A1 Tripodo, Claudio
YR 2021
UL http://medrxiv.org/content/early/2021/09/19/2021.07.28.21261117.abstract
AB The germinal center (GC) reaction results in the selection of B-cells acquiring effector Ig secreting ability by progressing towards plasmablastic differentiation. This transition is associated with exclusion from the GC microenvironment. The aberrant expansion of plasmablastic elements within the GC fringes configures an atypical condition, the biological characteristics of which have not been defined yet. We investigated the in situ immunophenotypical and transcriptional characteristics of a non-clonal germinotropic expansion of plasmablastic elements (GEx) occurring in the tonsil of a young patient. Compared to neighboring GC and peri-follicular regions, the GEx showed a distinctive signature featuring key regulators of plasmacytic differentiation, cytokine signaling, and cell metabolism. The GEx signature was tested in the setting of diffuse large B-cell lymphoma (DLBCL) as a prototypical model of lymphomagenesis encompassing transformation at different stages of GC and post-GC functional differentiation. The signature outlined DLBCL clusters with different immune microenvironment composition and enrichment in genetic subtypes.Significance This report represents the first insight into the transcriptional features of a germinotropic plasmablastic burst, shedding light into the molecular hallmarks of B cells undergoing plasmablastic differentiation and aberrant expansion within the non-canonical setting of the GC microenvironment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementItalian Cancer Research Foundation (AIRC) 22145 to C.T. Italian Ministry of Education University and Research 2017K7FSYBAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Palermo Institutional Review Board approval 05/2018All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNormalized gene expression data generated in the Digital Spatial Profiling experiment will be made available on request.